The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> January 15, 2016

Interview with the CEO & President: Biota Pharmaceuticals, Inc. (NASDAQ:BOTA)

Patti, Joseph M.
Joseph M. Patti, Ph.D. was appointed Chief Executive Office and President of Biota Pharmaceuticals, Inc. on October 1, 2014. Dr. Patti joined the company on November 12, 2012, and served as its Executive Vice President of Corporate Development and Strategy until October 1, 2014. Prior to joining the company, Dr. Patti co-founded Inhibitex, Inc. in 1998, and served as its Chief Scientific Officer and Senior Vice President of Research and Development from 2007 until it was acquired by Bristol Myers Squibb in February 2012. He also served as its Chief Scientific Officer and Vice President of Research and Development from 2005 to 2007, and as Vice President, Preclinical Development prior to that. Before co-founding Inhibitex, Inc. in 1998, Dr. Patti was an Assistant Professor at Texas A&M's Institute of Biosciences and Technology, and also served on the faculty at the University of Texas Health Science Center Graduate School of Biomedical Sciences. Dr. Patti is currently a Director of SciStem Therapeutics, Inc., a privately held company focused on developing cellular therapies for bone healing and musculoskeletal indications in both human and animal health. Dr. Patti was a director of Inhibitex, Inc. from 1998 to 2005. Dr. Patti received a B.S. in microbiology from the University of Pittsburgh, an MSPH from the University of Miami, School of Medicine and a Ph.D. in biochemistry from the University of Alabama at Birmingham. Profile
TWST: Can you provide a brief overview of the company and its core technology?

Dr. Patti: Biota is focused on and has expertise in the discovery and development of

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy